Oct 7th, 2022 - WAILEA, Hawaii — In this video from Hawaiian Eye, Sumit “Sam” Garg, MD, discusses modular accommodating lens technologies in development, offering patients depth of focus and stability without any rings on the IOLs.

Feb 27th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Andrew G. Lee, MD, discusses the monocular temporal crescent and how it can be identified.

Feb 26th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Michelle K. Rhee, MD, discusses the importance of contact lenses in serving younger patients. Rhee introduces the Contact Lens Curriculum for Ophthalmology Residents, a free online educational platform that provides essential contact lens knowledge.

Feb 20th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Andrew G. Lee, MD, discusses ways to differentiate between glaucoma and nonglaucomatous neuro-ophthalmic disease.

Feb 19th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Ronald R. Krueger, MD, discusses strategies for early detection of keratoconus and the benefits of performing cross-linking at an early stage.

Feb 13th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Paul Smith, president and chief operating officer of Orasis, discusses the company’s presbyopia correction candidate and the state of presbyopia management.

Feb 11th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Laura M. Periman, MD, discusses some of the factors, including cosmetics and lifestyle, that contribute to ocular surface disease.

Feb 10th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, John A. Hovanesian, MD, FACS, discusses the process of selecting specific IOLs to fit certain patients to achieve the best possible outcomes.

Feb 9th, 2022 - WAIKOLOA, Hawaii — Monofocal IOLs remain an important option in cataract surgery, according to a presentation at Hawaiian Eye 2022. Julie Schallhorn, MD, MS, said monovision has been a staple in the treatment of presbyopia dating to the mid-1990s and provides good outcomes for patients. “It’s got fairly high patient-reported satisfaction rates and fairly good function,” she said. “It remains ve...

Feb 9th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Laura M. Periman, MD, discusses superior limbic keratoconjunctivitis and the potential use of neuromodulators to ease patients’ symptoms.

Feb 8th, 2022 - WAIKOLOA, Hawaii — Swept-source OCT and total keratometry can help improve IOL calculations in patients who have previously undergone laser vision correction, according to a presentation here. At Hawaiian Eye 2022, Preeya K. Gupta, MD, said there are several reasons why a post-refractive cornea can cause problems when determining which IOL to use. First, there is a keratometric index of refract...

Feb 7th, 2022 - WAIKOLOA, Hawaii — With several good MIGS options, the choice often comes down to matching the procedure with the patient, according to a presentation at Hawaiian Eye 2022. John Berdahl, MD, said devices such as the Hydrus microstent (Ivantis/Alcon) and the iStent (Glaukos) have shown efficacy in reducing IOP and medications in patients with glaucoma. “So, how do you choose?” Berdahl said. “I a...

Feb 7th, 2022 - WAIKOLOA, Hawaii — Brolucizumab 6 mg demonstrates a favorable benefit-risk profile in the treatment of patients with diabetic macular edema, according to a presentation at Retina 2022. “To conclude on the summary of all three of these clinical trials, brolucizumab 6 mg was noninferior to aflibercept in respect to visual acuity at week 52 with fewer injections in the KESTREL and KITE study,” Mic...

Feb 7th, 2022 - WAIKOLOA, Hawaii — Hypersonic vitrectomy is a relatively new method with the potential to innovate vitreoretinal surgery, but surgeons have more to learn about it, according to a presenter at Retina 2022. “It will be easier for all of the things that we do for vitreoretinal surgery, but we are definitely still learning about it,” Sunir J. Garg, MD, FACS, FASRS, said. The Vitesse hypersonic vitr...

Feb 6th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Greg Kunst, president and CEO of Aurion Biotech, discusses a cell therapy strategy for treating corneal epithelial disease. The therapy is currently undergoing clinical trials in Japan and El Salvador. Aurion Biotech plans to submit an investigational new drug application to the FDA later this year.

Feb 5th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Mike Padilla, vice president of marketing at Alimera Sciences, discusses several trials. Padilla highlights the NEW DAY study, comparing Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg) as baseline therapy with aflibercept in patients with diabetic macular edema.

Feb 4th, 2022 - WAIKOLOA, Hawaii — When performing surgery on patients with uveitis, key points include controlling preoperative inflammation and being willing to question a diagnosis, according to a speaker at Retina 2022. “Just remember, when you’re doing surgery on these patients, No. 1, make sure you’re controlling the inflammation pre-surgery and post-surgery,” Sunil K. Srivastava, MD, said. Although many...

Feb 4th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Audrey Talley Rostov, MD, discusses strategies for handling patients who are dissatisfied after refractive cataract surgery.

Feb 4th, 2022 - WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Femida Kherani, MD, reviews the “ABCs” of performing upper-lid blepharoplasties.

Feb 3rd, 2022 - WAIKOLOA, Hawaii — Systemic effects of anti-VEGF in retinopathy of prematurity have not been ruled out, so it may be wise to use bevacizumab in lower doses or switch to agents with less systemic exposure, according to one presenter. “The BEAT-ROP study demonstrated a beneficial effect for bevacizumab vs. laser in the treatment of zone I, stage 3+ ROP. But one thing I didn’t like was the complet...